Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2018-11-15
2019-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes
NCT03106311
Fetal and Maternal Outcome in Preterm Premature Rupture of Membranes (PPROM)
NCT03491826
PROMComplete for Determination of Rupture of Fetal Membranes
NCT02369601
Preterm Premature Rupture of Membranes, Outpatient Management vs Inpatient Management
NCT02548013
Outpatient Management of Preterm Prelabor Rupture of Membranes
NCT05755841
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PPROM from 20- less than 28 weeks
pregnant ladies with PROM from 20 - 28 weeks
AmnioQuickDuo+
AmnioQuickDuo+ kit for detection of PROM
PROM from more than 28 weeks - less than 37 weeks
pregnant ladies with PROM from more than 28- less than37 weeks
AmnioQuickDuo+
AmnioQuickDuo+ kit for detection of PROM
control group pregnant ladies in labour after 37 weeks
control group pregnant ladies in labour after 37 weeks with rupture of membrane in labour or in cs
AmnioQuickDuo+
AmnioQuickDuo+ kit for detection of PROM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AmnioQuickDuo+
AmnioQuickDuo+ kit for detection of PROM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
National Research Centre, Egypt
OTHER
Aljazeera Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Alalfy
Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud Alalfy
Role: PRINCIPAL_INVESTIGATOR
Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasralainy Hospital
Cairo, , Egypt
Algazeerah
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ahmed Elgazzar, M.D
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROM by AmnioQuick Duo+
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.